{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:14:59Z","timestamp":1783473299788,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51561-4","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:01:43Z","timestamp":1778266903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and prognosis of acute myeloid leukemia and plasma cell neoplasms with bidirectional occurrence: a retrospective population-based study"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhihong","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"51561_CR1","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/cncr.22233","volume":"107","author":"B Deschler","year":"2006","unstructured":"Deschler, B. & L\u00fcbbert, M. Acute myeloid leukemia: Epidemiology and etiology. Cancer 107, 2099\u20132107. https:\/\/doi.org\/10.1002\/cncr.22233 (2006).","journal-title":"Cancer"},{"key":"51561_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","volume":"10","author":"S Venugopal","year":"2024","unstructured":"Venugopal, S. & Sekeres, M. A. Contemporary management of acute myeloid leukemia: A review. JAMA Oncol. 10, 1417\u20131425. https:\/\/doi.org\/10.1001\/jamaoncol.2024.2662 (2024).","journal-title":"JAMA Oncol."},{"key":"51561_CR3","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.ejca.2015.08.003","volume":"51","author":"R De Angelis","year":"2015","unstructured":"De Angelis, R. et al. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000\u20132007: Results of EUROCARE-5 population-based study. Eur. J. Cancer 51, 2254\u20132268. https:\/\/doi.org\/10.1016\/j.ejca.2015.08.003 (2015).","journal-title":"Eur. J. Cancer"},{"key":"51561_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/pgmj.62.734.1131","volume":"62","author":"D Maharaj","year":"1986","unstructured":"Maharaj, D. & Dolan, G. Acute myeloblastic leukaemia associated with solitary plasmacytoma of the ilium. Postgrad. Med. J. 62, 1131\u20131132. https:\/\/doi.org\/10.1136\/pgmj.62.734.1131 (1986).","journal-title":"Postgrad. Med. J."},{"key":"51561_CR5","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.3892\/ol.2018.8992","volume":"16","author":"S Ge","year":"2018","unstructured":"Ge, S., Zhu, G. & Yi, Y. Extramedullary plasmacytoma of the larynx: Literature review and report of a case who subsequently developed acute myeloid leukemia. Oncol. Lett. 16, 2995\u20133004. https:\/\/doi.org\/10.3892\/ol.2018.8992 (2018).","journal-title":"Oncol. Lett."},{"key":"51561_CR6","first-page":"265","volume":"79","author":"T Ohmori","year":"1984","unstructured":"Ohmori, T., Kono, H., Kajiwara, S., Arita, N. & Tabei, R. Primary colonic plasmacytoma associated with acute myelogenous leukemia. Am. J. Gastroenterol. 79, 265\u2013269 (1984).","journal-title":"Am. J. Gastroenterol."},{"key":"51561_CR7","first-page":"81","volume":"77","author":"A Miliani","year":"1986","unstructured":"Miliani, A., Breschi, C. & Di Guglielmo, R. [A case of smoldering plasmacytoma with development into acute myeloid leukemia]. Recenti Prog. Med. 77, 81\u201383 (1986).","journal-title":"Recenti Prog. Med."},{"key":"51561_CR8","first-page":"311","volume":"73","author":"B Desablens","year":"1986","unstructured":"Desablens, B., Gontier, M. F., Stoppa, R. & Messerschmitt, J. [Double breast and vertebral plasmacytoma. Acute myeloblastic leukemia 8 years later]. Bull. Cancer 73, 311\u2013315 (1986).","journal-title":"Bull. Cancer"},{"key":"51561_CR9","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3346\/jkms.2017.32.7.1072","volume":"32","author":"F Habibzadeh","year":"2017","unstructured":"Habibzadeh, F. Statistical data editing in scientific articles. J. Korean Med. Sci. 32, 1072\u20131076. https:\/\/doi.org\/10.3346\/jkms.2017.32.7.1072 (2017).","journal-title":"J. Korean Med. Sci."},{"key":"51561_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.10","volume":"2","author":"A Khwaja","year":"2016","unstructured":"Khwaja, A. et al. Acute myeloid leukaemia. Nat. Rev. Dis. Primers. 2, 16010. https:\/\/doi.org\/10.1038\/nrdp.2016.10 (2016).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"51561_CR11","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1200\/JCO.2014.55.1564","volume":"32","author":"HD Klepin","year":"2014","unstructured":"Klepin, H. D., Rao, A. V. & Pardee, T. S. Acute myeloid leukemia and myelodysplastic syndromes in older adults. J. Clin. Oncol. 32, 2541\u20132552. https:\/\/doi.org\/10.1200\/JCO.2014.55.1564 (2014).","journal-title":"J. Clin. Oncol."},{"key":"51561_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319366121","volume":"121","author":"J-F Li","year":"2024","unstructured":"Li, J.-F. et al. Aging and comprehensive molecular profiling in acute myeloid leukemia. Proc. Natl. Acad. Sci. U. S. A. 121, e2319366121. https:\/\/doi.org\/10.1073\/pnas.2319366121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"51561_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","volume":"15","author":"SK Kumar","year":"2018","unstructured":"Kumar, S. K. & Rajkumar, S. V. The multiple myelomas - Current concepts in cytogenetic classification and therapy. Nat. Rev. Clin. Oncol. 15, 409\u2013421. https:\/\/doi.org\/10.1038\/s41571-018-0018-y (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"51561_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/02841860151116321","volume":"40","author":"E Kimby","year":"2001","unstructured":"Kimby, E., Nygren, P., Glimelius, B., SBU-group, Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in acute myeloid leukaemia. Acta Oncol. 40, 231\u2013252. https:\/\/doi.org\/10.1080\/02841860151116321 (2001).","journal-title":"Acta Oncol."},{"key":"51561_CR15","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo, C. D., Erba, H. P., Freeman, S. D. & Wei, A. H. Acute myeloid leukaemia. Lancet 401, 2073\u20132086. https:\/\/doi.org\/10.1016\/S0140-6736(23)00108-3 (2023).","journal-title":"Lancet"},{"key":"51561_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","volume":"29","author":"A Burnett","year":"2011","unstructured":"Burnett, A., Wetzler, M. & L\u00f6wenberg, B. Therapeutic advances in acute myeloid leukemia. J. Clin. Oncol. 29, 487\u2013494. https:\/\/doi.org\/10.1200\/JCO.2010.30.1820 (2011).","journal-title":"J. Clin. Oncol."},{"key":"51561_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11899-019-00499-8","volume":"14","author":"A Pham","year":"2019","unstructured":"Pham, A. & Mahindra, A. Solitary plasmacytoma: A review of diagnosis and management. Curr. Hematol. Malig. Rep. 14, 63\u201369. https:\/\/doi.org\/10.1007\/s11899-019-00499-8 (2019).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"51561_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijrobp.2023.11.039","volume":"119","author":"P Fang","year":"2024","unstructured":"Fang, P. et al. Management and outcomes of patients with refractory solitary plasmacytoma after treatment with definitive radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 119, 193\u2013199. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.039 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"51561_CR19","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.3324\/haematol.2017.171876","volume":"103","author":"E Ladikou","year":"2018","unstructured":"Ladikou, E. et al. Clonal evolution in the transition from cutaneous disease to acute leukemia suggested by liquid biopsy in blastic plasmacytoid dendritic cell neoplasm. Haematologica 103, e196\u2013e199. https:\/\/doi.org\/10.3324\/haematol.2017.171876 (2018).","journal-title":"Haematologica"},{"key":"51561_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","volume":"21","author":"JM Klco","year":"2021","unstructured":"Klco, J. M. & Mullighan, C. G. Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat. Rev. Cancer 21, 122\u2013137. https:\/\/doi.org\/10.1038\/s41568-020-00315-z (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"51561_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41568-020-0260-3","volume":"20","author":"M Yamashita","year":"2020","unstructured":"Yamashita, M., Dellorusso, P. V., Olson, O. C. & Passegu\u00e9, E. Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis. Nat. Rev. Cancer. 20, 365\u2013382. https:\/\/doi.org\/10.1038\/s41568-020-0260-3 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"51561_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood.2025029967","volume":"146","author":"N Duployez","year":"2022","unstructured":"Duployez, N. et al. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood. Blood 146, 397. https:\/\/doi.org\/10.1182\/blood.2025029967 (2022).","journal-title":"Blood"},{"issue":"14","key":"51561_CR23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024028199","volume":"146","author":"P Goel","year":"2025","unstructured":"Goel, P. et al. The acute myeloid leukemia microenvironment impairs neutrophil maturation and function through NF\u03baB signaling. Blood blood.2024028199. https:\/\/doi.org\/10.1182\/blood.2024028199 (2025).","journal-title":"Blood"},{"key":"51561_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.20.00475","volume":"39","author":"S Khaldoyanidi","year":"2021","unstructured":"Khaldoyanidi, S., Nagorsen, D., Stein, A., Ossenkoppele, G. & Subklewe, M. Immune biology of acute myeloid leukemia: Implications for immunotherapy. J. Clin. Oncol. 39, 419\u2013432. https:\/\/doi.org\/10.1200\/JCO.20.00475 (2021).","journal-title":"J. Clin. Oncol."},{"key":"51561_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10238-025-01794-w","volume":"25","author":"F He","year":"2025","unstructured":"He, F., Tian, T., Qiao, S. & Xing, L. The efficacy and safety of venetoclax combined with decitabine in elderly patients with acute myeloid leukemia: A systematic review and meta-analysis. Clin. Exp. Med. 25, 239. https:\/\/doi.org\/10.1007\/s10238-025-01794-w (2025).","journal-title":"Clin. Exp. Med."},{"key":"51561_CR26","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1182\/blood.2024024009","volume":"145","author":"AH Wei","year":"2025","unstructured":"Wei, A. H., Loo, S. & Daver, N. How I treat patients with AML using azacitidine and venetoclax. Blood 145, 1237\u20131250. https:\/\/doi.org\/10.1182\/blood.2024024009 (2025).","journal-title":"Blood"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51561-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51561-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51561-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:43:56Z","timestamp":1783471436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51561-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51561"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51561-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study utilized publicly available, de-identified data from the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute (NCI). All data were secondary in nature and did not involve direct interaction with human subjects. The establishment and use of the SEER database have received appropriate ethical exemptions. The requirement for obtaining individual patient consent was waived due to the public and anonymous nature of the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Not applicable. This study did not use any identifiable images, data, or details of individuals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"21167"}}